Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres
The FOXFIRE (5-Fluorouracil, OXaliplatin and Folinic acid ± Interventional Radio-Embolisation) clinical trial combined systemic chemotherapy (OxMdG: Oxaliplatin, 5-fluorouracil and folic acid) with Selective Internal Radiation Therapy (SIRT or radio-embolisation) using yttrium-90 resin micr...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
MDPI
2019
|
| _version_ | 1797067198960762880 |
|---|---|
| author | Winter, H Rassam, J Virdee, PS Goldin, R Pitcheshwar, P Weaver, K Primrose, J Berry, DP Wasan, HS Sharma, RA |
| author_facet | Winter, H Rassam, J Virdee, PS Goldin, R Pitcheshwar, P Weaver, K Primrose, J Berry, DP Wasan, HS Sharma, RA |
| author_sort | Winter, H |
| collection | OXFORD |
| description | The FOXFIRE (5-Fluorouracil, OXaliplatin and Folinic acid ± Interventional Radio-Embolisation) clinical trial combined systemic chemotherapy (OxMdG: Oxaliplatin, 5-fluorouracil and folic acid) with Selective Internal Radiation Therapy (SIRT or radio-embolisation) using yttrium-90 resin microspheres in the first-line management for liver-dominant metastatic colorectal cancer (CRC). We report clinical outcomes for patients having hepatic resection after this novel combination therapy and an exploratory analysis of histopathology. Multi-Disciplinary Teams deemed all patients inoperable before trial registration and reassessed them during protocol therapy. Proportions were compared using Chi-squared tests and survival using Cox models. FOXFIRE randomised 182 participants to chemotherapy alone and 182 to chemotherapy with SIRT. There was no statistically significant difference in the resection rate between groups: Chemotherapy alone was 18%, (<i>n</i> = 33); SIRT combination was 21% (<i>n</i> = 38) (<i>p</i> = 0.508). There was no statistically significant difference between groups in the rate of liver surgery, nor in survival from time of resection (hazard ratio (HR) = 1.55; 95% confidence interval (CI) = 0.83-2.89). In the subgroup studied for histopathology, microsphere density was highest at the tumour periphery. Patients treated with SIRT plus chemotherapy displayed lower values of viable tumour in comparison to those treated with chemotherapy alone (<i>p</i> < 0.05). This study promotes the feasibility of hepatic resection following SIRT. Resin microspheres appear to preferentially distribute at the tumour periphery and may enhance tumour regression. |
| first_indexed | 2024-03-06T21:52:56Z |
| format | Journal article |
| id | oxford-uuid:4bee5a08-53ed-41ae-8a4c-2609a46cc0b9 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:52:56Z |
| publishDate | 2019 |
| publisher | MDPI |
| record_format | dspace |
| spelling | oxford-uuid:4bee5a08-53ed-41ae-8a4c-2609a46cc0b92022-03-26T15:46:29ZHepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheresJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4bee5a08-53ed-41ae-8a4c-2609a46cc0b9EnglishSymplectic ElementsMDPI2019Winter, HRassam, JVirdee, PSGoldin, RPitcheshwar, PWeaver, KPrimrose, JBerry, DPWasan, HSSharma, RAThe FOXFIRE (5-Fluorouracil, OXaliplatin and Folinic acid ± Interventional Radio-Embolisation) clinical trial combined systemic chemotherapy (OxMdG: Oxaliplatin, 5-fluorouracil and folic acid) with Selective Internal Radiation Therapy (SIRT or radio-embolisation) using yttrium-90 resin microspheres in the first-line management for liver-dominant metastatic colorectal cancer (CRC). We report clinical outcomes for patients having hepatic resection after this novel combination therapy and an exploratory analysis of histopathology. Multi-Disciplinary Teams deemed all patients inoperable before trial registration and reassessed them during protocol therapy. Proportions were compared using Chi-squared tests and survival using Cox models. FOXFIRE randomised 182 participants to chemotherapy alone and 182 to chemotherapy with SIRT. There was no statistically significant difference in the resection rate between groups: Chemotherapy alone was 18%, (<i>n</i> = 33); SIRT combination was 21% (<i>n</i> = 38) (<i>p</i> = 0.508). There was no statistically significant difference between groups in the rate of liver surgery, nor in survival from time of resection (hazard ratio (HR) = 1.55; 95% confidence interval (CI) = 0.83-2.89). In the subgroup studied for histopathology, microsphere density was highest at the tumour periphery. Patients treated with SIRT plus chemotherapy displayed lower values of viable tumour in comparison to those treated with chemotherapy alone (<i>p</i> < 0.05). This study promotes the feasibility of hepatic resection following SIRT. Resin microspheres appear to preferentially distribute at the tumour periphery and may enhance tumour regression. |
| spellingShingle | Winter, H Rassam, J Virdee, PS Goldin, R Pitcheshwar, P Weaver, K Primrose, J Berry, DP Wasan, HS Sharma, RA Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres |
| title | Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres |
| title_full | Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres |
| title_fullStr | Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres |
| title_full_unstemmed | Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres |
| title_short | Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres |
| title_sort | hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the foxfire clinical trial clinical outcomes and distribution of microspheres |
| work_keys_str_mv | AT winterh hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT rassamj hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT virdeeps hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT goldinr hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT pitcheshwarp hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT weaverk hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT primrosej hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT berrydp hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT wasanhs hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres AT sharmara hepaticresectionfollowingselectiveinternalradiationtherapyforcolorectalcancermetastasesinthefoxfireclinicaltrialclinicaloutcomesanddistributionofmicrospheres |